Abigail L. Jenkins - 10 May 2024 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AQST	Non-Qualified Stock Option (right to buy)	Award	$0	-57,000	-50%	$0.000000	57,000	10 May 2024	Common Stock	57,000	$3.09	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option vests in three equal annual installments beginning on May 10, 2025.